The U.S. Food and Drug Administration has approved SPEVIGO (spesolimab-sbzo) as the first treatment option for generalized pustular psoriasis (GPP) flares in adults.
This article was originally published on MedicalXpress.com
FDA approves SPEVIGO for generalized pustular psoriasis flares
You may also be interested in:
The Latest
Best home maintenance tips and tricks that will save you time and money
Time….. Time is always the biggest factor when it comes to proper or terrible home maintenance. We have asked Toronto based home maintenance company, “what is the best way and what might be the worst property […]
The Latest
Colorful sweets may look tasty, but some researchers question whether synthetic dyes may pose health risks to your colon and rectum
Early-onset colorectal cancer incidence among the young, defined as those under age 50, has been rising globally since the early 1990s. Rates for colon and rectal cancers are expected to increase by 90% and 124%, respectively, by 2030. […]
The Latest
Why you should stop buying vitamins and get more sleep instead
Almost half of all Canadians regularly take at least one nutritional supplement such as vitamins, minerals, fibre supplements, antacids and fish oils. Many of these individuals are healthy and hoping to improve general well-being or prevent chronic […]
Read More:
-
A cap-and-invest strategy to cut transportation-related carbon emissions could provide substantial health benefits to children in New York City, with greater benefits among Black and [...]
-
Playgrounds are fun and can provide a great opportunity for exercise and family togetherness. But did you know that youths age 17 and younger are [...]
-
According to a new modeling study, published in JAMA Pediatrics, the number of children estimated to have experienced the death of a parent or caregiver [...]
